Korea University Guro Hospital clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: FLOW-DCB · Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies Recruitment opened
- Minor: Impact of CES1 Genotype on Remimazolam Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-18 | NCT07944209 Remimazolam Induction Methods in Robotic Cholecystectomy | Completed |
Active trials by phase
| Phase 2 | 2 | |
| Phase 4 | 2 |
Not charted: 9 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Coronary Artery Disease (3) · Heart Disease (3) · Asthma (1) · Breast Cancer (1) · COPD (1) · Hypertension (1) · Lung Cancer (1) · Ovarian Cancer (1)
Get alerts when Korea University Guro Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.